Document Detail


Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes.
MedLine Citation:
PMID:  16948644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aetiology of multiple sclerosis (MS) is still not fully understood. Infectious agents are believed to play a role in the development of this multifactorial disease. Cases in which this disease occurs after administration of both plasma-derived and recombinant hepatitis B vaccines have been reported. In this study, we compared a group of 11 MS patients who developed first clinical symptoms after hepatitis B vaccination (group I) with 71 MS patients who were never vaccinated against hepatitis B and were negative for hepatitis B serology (group II), and 20 healthy controls (group III). Mean age was 27.75 years (19-39) in group I, 30.16 years (18-50) in group II, and 34.4 years (18-50) in group III. Mean attack rate after 2 years was 1.5 in group I and 1.63 in group II. Mean Expanded Disability Status Scale score after 2 years was 1.31 in group I and 1.89 in group II. Human leucocyte antigen (HLA) typing and serology for hepatitis B surface antigen were performed in all groups. In groups I and II, HLA-DR2 was more frequent than in normal healthy subjects. This reflects the general role of HLA in the pathogenesis of MS but suggests that antigen presentation by different HLA is not involved in the development of MS after hepatitis B vaccination. Since there was no difference in the clinical features between vaccinated and nonvaccinated MS patients, this study supports recent reports that hepatitis B vaccination is safe in MS patients and that hepatitis B vaccination is not involved in the development of MS.
Authors:
S Ozakbas; E Idiman; B Yulug; B Pakoz; H Bahar; Z Gulay
Related Documents :
9178394 - Inflammatory joint disease after immunizations. a report of two cases.
12079904 - Safety and efficacy of vaccination against hepatitis b in patients with rheumatoid arth...
7873304 - Hepatitis b vaccination: knowledge among clinical dental staff and students in dundee.
17630224 - Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antige...
18694794 - Clinicopathologic understanding and control of varicella-zoster virus infection.
21356134 - The impact of media coverage on the transmission dynamics of human influenza.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Tissue antigens     Volume:  68     ISSN:  0001-2815     ISO Abbreviation:  Tissue Antigens     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-09-04     Completed Date:  2006-11-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0331072     Medline TA:  Tissue Antigens     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  235-8     Citation Subset:  IM    
Affiliation:
Department of Neurology, Dokuz Eylul University Faculty of Medicine, Balcova, Izmir, Turkey. serkan.ozakbas@deu.edu.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Female
HLA-DR2 Antigen / immunology*
Haplotypes
Hepatitis B / prevention & control
Hepatitis B Vaccines / adverse effects*,  immunology
Humans
Male
Middle Aged
Multiple Sclerosis / etiology*,  immunology
Vaccination
Chemical
Reg. No./Substance:
0/HLA-DR2 Antigen; 0/Hepatitis B Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A crypto-Dravidian origin for the nontribal communities of South India based on human leukocyte anti...
Next Document:  HLA-B35 upregulates the production of endothelin-1 in HLA-transfected cells: a possible pathogenetic...